EMBOLIZATION MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Embolization Market- Overview Researchers and key players are focusing on the development of novel embolization products for the treatment of chronic diseases such as tumor, hemorrhage and others, which is expected to drive growth of the global embolization market over the forecast period. For instance, in January 2021, MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, received the U.S. Food and Drug Administration approval for its PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System, is designed with the latest MicroBraid technology, which features a lower profile delivery system compatible with the VIA 17 microcatheter, and includes additional device configurations. Moreover, in November 2020, Fluidx Medical Technology, a U.S.-based embolic devices manufacturing company, introduced its novel GPX Embolic Device. It is an innovative embolic designed to combine the benefits of other embolics such as coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term occlusions. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/embolization-market-4473 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Increasing incidence of chronic diseases is expected to drive the market growth over the forecast period. • The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, neurovascular diseases, and others is expected to drive growth of the global embolization market over the forecast period.
• For instance, according to the World Health Organization statistics published in March 2021, cancer is the second leading cause of deaths globally, and is responsible for about 10 million deaths per year, across the globe, and about one in six deaths is due to cancer. Furthermore, according to the same source, an estimated 9.6 million deaths occurred due to cancer in 2018, globally. • Additionally, according to the Global Burden of Disease (GBD), an article published in the National Center for Biotechnology Information (NCBI) in July 2020, prevalence of ischemic heart disease is increasing. The GBD datasets analyzed that in 2020, the prevalence rate of ischemic heart disease was 1,655 per 100,000 global population, and is expected to exceed 1,845 by 2030. • Moreover, according to the Brain Aneurysm Foundation report 2020, there are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half of the victims are younger than 50 years of age. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/4473 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Embolization Market– Impact of Coronavirus (Covid-19) Pandemic • Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in over 122 million infected individuals worldwide, as of March 19, 2021. • The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. Supply of key materials such as probes required for interventional ablation have been severely disrupted due to forced quarantine, and imposed lockdowns in various countries. This has led to disruption in the link between regional warehouses, the transportation of materials between regions cannot be carried out successfully. This shortage of medical devices such as embolic coils, plugs required for embolization procedures have affected the supply chain of the global embolization market.
• Moreover, the hospitals are delaying the uterine fibroid embolization of patients who are stable and the surgery can be postponed, or suggesting patients to undergo the treatment from outpatient’s services, to reduce the high risk of getting infected by the COVID-19.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4698 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
© Coherent market Insights. All Rights Reserved